These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 9861558
1. Evolution of the clinical manifestations of infection during the course of febrile neutropenia in patients with malignancy. Dompeling EC, Donnelly JP, Raemaekers JM, Deresinski SC, Feld R, De Pauw BE. Infection; 1998; 26(6):349-54. PubMed ID: 9861558 [Abstract] [Full Text] [Related]
6. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. Pizzo PA, Hathorn JW, Hiemenz J, Browne M, Commers J, Cotton D, Gress J, Longo D, Marshall D, McKnight J. N Engl J Med; 1986 Aug 28; 315(9):552-8. PubMed ID: 3526155 [Abstract] [Full Text] [Related]
7. A randomized trial of Timentin and tobramycin versus piperacillin and tobramycin in febrile neutropenic patients. Mackie MJ, Reilly JT, Purohit S, Bartzokas CA. J Antimicrob Chemother; 1986 May 28; 17 Suppl C():219-24. PubMed ID: 3522529 [Abstract] [Full Text] [Related]
9. European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients. Croydon E, Weerts D. Chemioterapia; 1987 Jun 28; 6(2 Suppl):405-7. PubMed ID: 3334585 [No Abstract] [Full Text] [Related]
10. Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison. Corapcioglu F, Sarper N, Zengin E. Pediatr Hematol Oncol; 2006 Jun 28; 23(3):177-86. PubMed ID: 16517534 [Abstract] [Full Text] [Related]
12. Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer. Chuang YY, Hung IJ, Yang CP, Jaing TH, Lin TY, Huang YC. Pediatr Infect Dis J; 2002 Mar 28; 21(3):203-9. PubMed ID: 12005083 [Abstract] [Full Text] [Related]
14. Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer. Feliu J, Artal A, González Barón M, Berrocal A, Chacón I, García de Paredes ML, Espinosa E, Ordóñez A, Zamora P, Montero JM. Antimicrob Agents Chemother; 1992 Dec 28; 36(12):2816-20. PubMed ID: 1482151 [Abstract] [Full Text] [Related]